REGENERON PHARMACEUTICALS, INC. Shares Outstanding
REGENERON PHARMACEUTICALS, INC. (REGN) had Shares Outstanding of 94.41 million shares as of 2012-09-30, per its 10-Q filed 2012-10-24.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2012-10-24
- 2012-09-30: Shares outstanding (split-adjusted) 94.41M shares; Shares authorized (split-adjusted) 160.00M shares.
- 2012-06-30: Shares outstanding (split-adjusted) 93.94B shares; Shares authorized (split-adjusted) 160.00B shares.
- 2012-03-31: Shares outstanding (split-adjusted) 92.97B shares; Shares authorized (split-adjusted) 160.00B shares.
- 2011-12-31: Shares outstanding (split-adjusted) 90.69M shares; Shares authorized (split-adjusted) 160.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2012-09-30 | 94.41M shares 10-Q · filed 2012-10-24 | 160.00M shares 10-Q · filed 2012-10-24 |
| 2012-06-30 | 93.94B shares 10-Q · filed 2012-07-25 | 160.00B shares 10-Q · filed 2012-07-25 |
| 2012-03-31 | 92.97B shares 10-Q · filed 2012-04-26 | 160.00B shares 10-Q · filed 2012-04-26 |
| 2011-12-31 | 90.69M shares 10-Q · filed 2012-10-24 | 160.00M shares 10-Q · filed 2012-10-24 |
| 2011-09-30 | 90.42M shares 10-Q · filed 2011-10-27 | 160.00M shares 10-Q · filed 2011-10-27 |
| 2011-06-30 | 89.42M shares 10-Q · filed 2011-07-28 | 160.00M shares 10-Q · filed 2011-07-28 |
| 2011-03-31 | 88.55M shares 10-Q · filed 2011-05-03 | 160.00M shares 10-Q · filed 2011-05-03 |
| 2010-12-31 | 87.24M shares 10-K · filed 2012-02-21 | 160.00M shares 10-K · filed 2012-02-21 |
| 2010-09-30 | 80.04M shares 10-Q · filed 2010-10-28 | 160.00M shares 10-Q · filed 2010-10-28 |
| 2010-06-30 | 79.92M shares 10-Q · filed 2010-07-28 | 160.00M shares 10-Q · filed 2010-07-28 |
| 2009-12-31 | 78.86M shares 10-K · filed 2011-02-17 | 160.00M shares 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |